Published online first on June 30, 2009 [Clinical Cancer Research, 10.1158/1078-0432.CCR-09-0199] Development of Tumor-Reactive T Cells After Nonmyeloablative...
Clinical Cancer Research 15, 4415, July 1, 2009. Published Online First June 9, 2009; doi: 10.1158/1078-0432.CCR-08-3266 Stereotyped B-Cell Receptor Is an...
Cancer Research 69, 5424, July 1, 2009. doi: 10.1158/0008-5472.CAN-08-4252 Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic...
Copying first, words of wisdom from Natural Medicine - science blog: "It isn't very surprising that plants contain anti-cancer chemicals; they have being...
Personalized Anti-Cancer Vaccine, BiovaxID(R), Targeting B-Cell Lymphomas Available In Europe On A Named-Patient Basis 30 Jun 2009 Biovest International, Inc....
Researchers Pinpoint A New Enemy For Tumor Suppressor P53 27 Jun 2009 Researchers at The University of Texas M. D. Anderson Cancer Center have identified a...
Cancer Care Is Often Incomplete "Many people living with cancer report that their psychosocial health care needs are not well addressed in their care. At the...
B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity. G Ferrer, K Hodgson, E...
[Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors] W Xu, QD Shen, H Yu,...
Variable Contribution of Monoclonal Antibodies to ADCC in patients with chronic lymphocytic leukemia. James Weitzman, Monica Betancur, Laurent Boissel, Arthur...
Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing. Andrew G...
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Pau Abrisqueta, Arturo Pereira,...
Rife Revisited? Will scientists someday be able to 'dial up' an electromagnetic treatment for some people's cancer? Possibly, according to scientists at eight...
FDA requests additional information on Zevalin application. Dow Jones Newswires (7/6, Benn) reported, Spectrum Pharmaceuticals Inc. "said the US Food and Drug...
The statistics speak, I think, to the inadequacies of our health care system more than to the value of ALT med practices, which have, so far ,not been...
Cancer Research 69, 5424, July 1, 2009. Published Online First June 23, 2009; doi: 10.1158/0008-5472.CAN-08-4252 Spleen Tyrosine Kinase Is Overexpressed and...
(Haematologica 2009, 10.3324/haematol.2009.008979) Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies ...
Cancer Diagnosis – take part in our new video research blog from The Patients Voice Dear Friends Just a quick note to invite you to have a look at our new...
Greetings, Here's what we call the Bring List. The goal is help coordinate care and make the most of each consult. http://www.lymphomation.org/bringlist.pdf ...
Journal of Clinical Oncology, Vol 27, No 20 (July 10), 2009: pp. 3346-3353 Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's...
Journal of Clinical Oncology, Vol 27, No 20 (July 10), 2009: pp. 3398-3409 Approaches to the Management of Invasive Fungal Infections in Hematologic Malignancy...
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1...
Here's a conceptual approach I found interesting ... compelling is not too strong a word ... a value-based approach seems the correct framework on which to...
Annals of Oncology, doi:10.1093/annonc/mdp259 Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis...
Greetings, Our goal is to make the consideration of clinical trials more routine so we might accelerate progress against lymphomas and CLL. To help identify...
Blood First Edition Paper, prepublished online July 13, 2009; DOI 10.1182/blood-2009-03-212191. Lymphomas with concurrent BCL2 and MYC translocations: the...
Editors' Choice: Story of the Week Commentary 2009 Jul 15, Lee Schwartzberg, MD, PhD, Editor-in-Chief Oncologists increasingly consider the entire scope of...
Blood, 16 July 2009, Vol. 114, No. 3, pp. 638-646. Prepublished online as a Blood First Edition Paper on April 22, 2009; DOI 10.1182/blood-2008-12-196568. ...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
